What Is enVVeno Medical Corporation (NVNO) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, the balance of valuation evidence tilts cautious on enVVeno Medical Corporation at its current price of $10.48. The composite intrinsic value is estimated at $12.94 (+23.5% average return), with 4 models flagging overvaluation risk. The most optimistic model, Dynamic NAV, places fair value at $45.57 (+335.1%), while ML-RIV — the most conservative — estimates $0.11 (-99.0%). This +434.1% gap reflects genuine analytical uncertainty about enVVeno Medical Corporation's intrinsic worth.
What Do the Models Say About NVNO?
7 of 13 models are currently active for NVNO. Of these, 3 models suggest upside while 4 models suggest overvaluation. The Bayesian DCF estimates NVNO's intrinsic value at $4.59, implying -56.1% downside from the current price. See which stocks rank higher →
How Does NVNO Rank in Surgical & Medical Instruments & Apparatus?
Among 109 Surgical & Medical Instruments & Apparatus stocks, NVNO ranks #101 by Quality of Company score. CirclFi's QOC score of 4.1/10 evaluates 32 fundamental signals. A score of 4.1 reflects mixed fundamentals.
See all Most Undervalued Surgical & Medical Instruments & Apparatus Stocks →
enVVeno Medical Corporation operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.
Is NVNO a Value Trap?
CirclFi's Value Trap algorithm assigns NVNO a score of 36/100 (LOW). This indicates low risk. The financial profile does not exhibit typical value trap warning signs. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
7 of 13 models are active for enVVeno Medical Corporation. Moderate coverage provides meaningful perspective. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi Quality of Company (QOC) framework, which evaluates 32 signals including margin stability, revenue growth trajectory, leverage, and free cash flow generation, enVVeno Medical Corporation is rated at 4.1/10. This moderate-tier score shows mixed signals across our quality framework with notable weaknesses.
The gap between the most bullish and bearish model spans +434.1% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every NVNO valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across NVNO's 7 active models, average confidence is 20%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad